Skip to Main Content

Author Details

David N Brown
Memorial Sloan Kettering Cancer Center
2018
34
17
PMIDPaper TitleJournal TitlePublished Year
36007103High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer.Clin Cancer Res2023
37558129HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer.Mod Pathol2023
37607324Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma.J Clin Oncol2023
36323507<i>KIT</i> genetic alterations in breast cancer.J Clin Pathol2023
34949653Cancer-Causative Mutations Occurring in Early Embryogenesis.Cancer Discov2022
36551247Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer.Biomolecules2022
35999225ERα-LBD, an isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance.NPJ Breast Cancer2022
33021035The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.Mol Oncol2021
33622519Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer.Gynecol Oncol2021
33536276Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.Clin Cancer Res2021
33893322Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development.NPJ Breast Cancer2021
33527450Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.Histopathology2021
34470810Correction: Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer.Clin Cancer Res2021
34635660Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.NPJ Breast Cancer2021
34145282Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS.Nat Commun2021
33947695Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes.Clin Cancer Res2021
33429428Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial.J Natl Cancer Inst2021
32220886Whole-Exome Sequencing Analysis of the Progression from Non-Low-Grade Ductal Carcinoma <i>In Situ</i> to Invasive Ductal Carcinoma.Clin Cancer Res2020
33083532The genomic landscape of metastatic histologic special types of invasive breast cancer.NPJ Breast Cancer2020
32864625Alterations in <i>PTEN</i> and <i>ESR1</i> promote clinical resistance to alpelisib plus aromatase inhibitors.Nat Cancer2020
30467240Recurrent <i>MED12</i> exon 2 mutations in benign breast fibroepithelial lesions in adolescents and young adults.J Clin Pathol2019
31754629Erratum: Publisher Correction: Homologous recombination DNA repair defects in <i>PALB2</i>-associated breast cancers.NPJ Breast Cancer2019
31768066High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.Nat Med2019
32914019Endometrial Cancers in <i>BRCA1</i> or <i>BRCA2</i> Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair Defects.JCO Precis Oncol2019
31360903The Landscape of Somatic Genetic Alterations in Breast Cancers from <i>CHEK2</i> Germline Mutation Carriers.JNCI Cancer Spectr2019
30972907Solid pseudopapillary neoplasms of the pancreas are dependent on the Wnt pathway.Mol Oncol2019
30791119Massively parallel sequencing analysis of benign melanocytic naevi.Histopathology2019
30843622Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinoma.Histopathology2019
30843621Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma.Histopathology2019
30675516Assessment of <i>HMGA2</i> and <i>PLAG1</i> rearrangements in breast adenomyoepitheliomas.NPJ Breast Cancer2019
30649385The Genomic Landscape of Mucinous Breast Cancer.J Natl Cancer Inst2019
30565721Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexa.Histopathology2019
30537512Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.Cancer Cell2018
30166553Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.Nat Commun2018
  • 1 - 34 of 34

Recommended Authors

Career Start Year 2017
Number of shared co-authors 0
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 1
University of British Columbia
Career Start Year 2014
Number of shared co-authors 1
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2014
Number of shared co-authors 4
Paris Sciences Lettres University PSL, Institut CURIE
Career Start Year 2012
Number of shared co-authors 12
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 7
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 10
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Institute of Cancer Sciences, University of Glasgow
Career Start Year 2006
Number of shared co-authors 2
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 14
Memorial Sloan Kettering Cancer Center
Career Start Year 2006
Number of shared co-authors 28
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 5
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 9
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 5
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 4
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 2
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 4
University of California
Career Start Year 2003
Number of shared co-authors 0
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 2
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 12
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 13
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 3
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 10
Monash University
Career Start Year 2000
Number of shared co-authors 29
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 3
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 5
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 8
University of British Columbia
Career Start Year 1994
Number of shared co-authors 12
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 12

Collaborators

Memorial Sloan-Kettering Cancer Center
Co-authored papers 31
Memorial Sloan Kettering Cancer Center
Co-authored papers 26
Memorial Sloan Kettering Cancer Center
Co-authored papers 23
Memorial Sloan Kettering Cancer Center
Co-authored papers 18
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Roswell Park Comprehensive Cancer Center
Co-authored papers 8
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
University of Basel
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Co-authored papers 2
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 2
Xijing Hospital, The Fourth Military Medical University
Co-authored papers 2
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Vanderbilt University Medical Center
Co-authored papers 2
Thomas Jefferson University Hospital
Co-authored papers 2